India Glycols Q1 FY27 results: PAT up 45% YoY on revenue growth
INDIAGLYCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 0.9 pts more than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
India Glycols posted Q1 FY27 standalone revenue of Rs 2,986.92 crores, up 19.3% YoY from Rs 2,503.03 crores. PAT rose 44.9% to Rs 76.59 crores. EBITDA grew to Rs 170.30 crores. Consolidated PAT was Rs 96.83 crores, up about 32% YoY. EPS stood at Rs 11.43 standalone. NCLT sanctioned the company demerger scheme for Spirits and Bio Pharma businesses on July 17, 2026. Limited review by auditors was clean.
Strong quarterly results with sharp PAT growth and NCLT demerger approval, which may unlock shareholder value as separate listed entities.